Mohit Mehtani, MD
Ophthalmology · Napa, CANPI 1770808339
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,759 and has fallen 92.3% since, to $135 in 2025.
Across 110 payments — averaging $53.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$861
- Alcon$606
- Regeneron Healthcare Solutions, Inc.$559
- Sight Sciences, Inc.$475
- Apellis Pharmaceuticals, Inc.$441
- Johnson & Johnson Surgical Vision, Inc.$386
- plus $3K from 22 others
What the payments were for
- Food & beverage$5,814100%
- Gifts$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 14 | $861 |
| Alcon | 13 | $606 |
| Regeneron Healthcare Solutions, Inc. | 14 | $559 |
| Sight Sciences, Inc. | 7 | $475 |
| Apellis Pharmaceuticals, Inc. | 6 | $441 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $386 |
| Rxsight Inc | 6 | $286 |
| Microsurgical Technology, Inc. | 1 | $242 |
| Biotissue Holdings Inc. | 4 | $223 |
| AbbVie(2 entities) | 5 | $219 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $214 |
| Aerie Pharmaceuticals, Inc. | 4 | $196 |
| Amgen | 4 | $185 |
| Iridex Corporation | 1 | $178 |
| Harrow Eye, LLC | 1 | $157 |
| Biogen | 1 | $116 |
| Sandoz | 1 | $91 |
| Oyster Point Pharma, Inc. | 3 | $67 |
| Omeros Corporation | 2 | $63 |
| Novartis | 3 | $49 |
| Bausch & Lomb Americas Inc. | 2 | $38 |
| Thea Pharma Inc. | 2 | $36 |
| Kala Pharmaceuticals, Inc. | 2 | $36 |
| Sun Pharmaceutical Industries Inc. | 1 | $26 |
| Akorn, Inc. | 1 | $24 |
| Dompe US, Inc. | 1 | $23 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Tarsus Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis IOL$796
- VABYSMO$387
- Syfovre$257
- IHEEZO$157
- OMNI$150
- TEPEZZA$150
- ORA$144
- RXSIGHT INJECTOR HANDPIECE$139
- RXSIGHT CONTACT LENS$139
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$139
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$139
- RXSIGHT INJECTOR CARTRIDGE$139
- Clareon$128
- TearCare SmartLid$128
- TEARCARE(TM) (2.2) SYSTEM KIT$128
- Rocklatan$125
- Rhopressa$125
- OMNI(R) SURGICAL SYSTEM (US)$125
- EYLEA$125
- EYLEA HD$125
How this compares
$5,834 in reported general payments places this provider in the 80th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorometholone | 46 | $4,744 |
| Latanoprost | 117 | $2,122 |
| Prednisolone Acetate | 48 | $1,811 |
| Brimonidine Tartrate | 13 | $1,168 |
| ErythromycinErythromycin Base | 101 | $1,124 |
| Ketorolac Tromethamine | 36 | $784 |
| MoxifloxacinMoxifloxacin Hcl | 33 | $769 |
| Timolol Maleate | 62 | $634 |
| Doxycycline Hyclate | 22 | $630 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 39 | $574 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 53 | $561 |
| Dorzolamide Hcl | 12 | $361 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Napa
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
- Srinivas SaddaPasadena$1M
- Sheri RowenNewport Beach$1M
- Savak TeymoorianLaguna Hills$955K
- Andrew MoshfeghiLos Angeles$895K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.